skip to primary navigationskip to content
 

Biotechnology Alumnus Takes Horizon Discovery Public

last modified May 22, 2014 11:59 AM

The future is bright for the department’s biotech alumnus and enterprise mentor Darrin Disley and his colleagues at  Horizon Discovery Group plc following the company’s March 2014 listing on AIM with a market capitalisation of £120.5 million. The placing, conducted by Panmure Gordon, has raised £68.6 million from institutional investors comprising £40 million for the Company before expenses and the sale of £28.6 million of Sale Shares, at a price of 180p per share. Shares in Horizon are expected to start trading on Thursday 27th March, under the ticker symbol “HZD”.

Horizon’s business, centred around the proprietary GENESISTM gene editing and X MANTM cell line platforms,  enables the understanding of the genetic basis of disease, the manipulation of genomes and the creation of genetically-defined human cell lines or “patients in a test tube”. This technology is becoming widely used in genomics research and the development of personalised medicines targeted to specific genetic drivers of diseases like cancer.  The company included blue chip firms AstraZeneca, Bayer, Boehringer Ingelheim, Genentech, Jannsen Pharmaceuticals, Merck & Co., Novartis Institutes of Biomedical Research and Takeda, amongst its 353 unique customers in 2013.

The cash raised will be used to enhance marketing of Horizon’s products and leveraged R&D programmes in their target markets, to expand sales and distribution channels, for product development and  in-licensing of new product ranges from third parties, as well as to increase the pipeline of R&D opportunities delivering downstream milestone and product royalties.

Darrin plans to continue to mentor postgraduates on the Bioscience Enterprise programme and to support Cambridge University Entrepreneurs, inspiring students with enterprising ambitions from across the University to create their own companies.  

Filed under:

Share this

RSS Feed Latest news

Machine learning predicts mechanical properties of porous materials

May 16, 2019

Machine learning can be used to predict the properties of a group of materials that, according to some, could be as important to the 21st century as plastics were to the 20th.

Alumna Fiona Erskine publishes “The Chemical Detective” book

May 10, 2019

Chemical Engineering alumna and writer Fiona Erskine publishes “The Chemical Detective”, a crime thriller with a chemical engineering protagonist.

New approach to drug discovery could lead to personalised treatment of neuropsychiatric disorders

May 09, 2019

Researchers from our Centre for Neuropsychiatric Research have developed a method that could drastically accelerate the search for new drugs to treat mental health disorders such as schizophrenia.

View all news

Upcoming events

CEB Research Conference 2019

Jun 25, 2019

Department of Chemical Engineering and Biotechnology, Philippa Fawcett Drive, Cambridge, CB3 0AS

Machine learning and AI in (bio)chemical engineering

Jul 08, 2019

Department of Chemical Engineering and Biotechnology, Philippa Fawcett Drive, Cambridge, CB3 0AS

Stokes200 Symposium

Sep 15, 2019

Pembroke College, Cambridge

VPF8 Viscoplastic Fluids: from Theory to Application 2019

Sep 16, 2019

Jesus College, Cambridge

Upcoming events